Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy ASLAN Pharmaceuticals stock | $2.97
Learn how to easily invest in ASLAN Pharmaceuticals stock.
ASLAN Pharmaceuticals Limited is a biotechnology business based in the US. ASLAN Pharmaceuticals shares (ASLN) are listed on the NASDAQ and all prices are listed in US Dollars. ASLAN Pharmaceuticals employs 18 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in ASLAN Pharmaceuticals
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ASLN – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
ASLAN Pharmaceuticals stock price (NASDAQ: ASLN)Use our graph to track the performance of ASLN stocks over time.
ASLAN Pharmaceuticals shares at a glance
|Latest market close||$2.97|
|52-week range||$1.26 - $6.75|
|50-day moving average||$3.17|
|200-day moving average||$3.17|
|Wall St. target price||$8.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.05|
Buy ASLAN Pharmaceuticals shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy ASLAN Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
ASLAN Pharmaceuticals price performance over time
|1 week (2021-07-21)||N/A|
|1 month (2021-07-01)||-11.08%|
|3 months (2021-04-30)||-8.05%|
|6 months (2021-01-28)||N/A|
|1 year (2020-07-28)||N/A|
|2 years (2019-07-28)||N/A|
|3 years (2018-07-28)||N/A|
|5 years (2016-07-28)||N/A|
ASLAN Pharmaceuticals financials
|Gross profit TTM||$79.8 million|
|Return on assets TTM||-20.58%|
|Return on equity TTM||-53.74%|
|Market capitalisation||$192.6 million|
TTM: trailing 12 months
Shorting ASLAN Pharmaceuticals shares
There are currently 1.7 million ASLAN Pharmaceuticals shares held short by investors – that's known as ASLAN Pharmaceuticals's "short interest". This figure is 8.8% up from 1.5 million last month.
There are a few different ways that this level of interest in shorting ASLAN Pharmaceuticals shares can be evaluated.
ASLAN Pharmaceuticals's "short interest ratio" (SIR)
ASLAN Pharmaceuticals's "short interest ratio" (SIR) is the quantity of ASLAN Pharmaceuticals shares currently shorted divided by the average quantity of ASLAN Pharmaceuticals shares traded daily (recently around 1.8 million). ASLAN Pharmaceuticals's SIR currently stands at 0.93. In other words for every 100,000 ASLAN Pharmaceuticals shares traded daily on the market, roughly 930 shares are currently held short.
However ASLAN Pharmaceuticals's short interest can also be evaluated against the total number of ASLAN Pharmaceuticals shares, or, against the total number of tradable ASLAN Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case ASLAN Pharmaceuticals's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 ASLAN Pharmaceuticals shares in existence, roughly 20 shares are currently held short) or 0.0344% of the tradable shares (for every 100,000 tradable ASLAN Pharmaceuticals shares, roughly 34 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against ASLAN Pharmaceuticals.
Find out more about how you can short ASLAN Pharmaceuticals stock.
ASLAN Pharmaceuticals share dividends
We're not expecting ASLAN Pharmaceuticals to pay a dividend over the next 12 months.
ASLAN Pharmaceuticals share price volatility
Over the last 12 months, ASLAN Pharmaceuticals's shares have ranged in value from as little as $1.26 up to $6.75. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ASLAN Pharmaceuticals's is 2.4059. This would suggest that ASLAN Pharmaceuticals's shares are significantly more volatile than the average for this exchange and represent a higher risk.
ASLAN Pharmaceuticals overview
ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase for the treatment of autoimmune conditions. It has a joint venture with Bukwang Pharmaceutical Co. , Ltd. to develop immuno-oncology therapeutics for markets targeting the AhR pathway. Its partners include Almirall, Array BioPharma, and CSL Limited. The company was founded in 2010 and is headquartered in Singapore.
ASLAN Pharmaceuticals in the news
Were Hedge Funds Right About ASLAN Pharmaceuticals Limited (ASLN)?
ASLAN Pharmaceuticals Announces Loan Facility Providing Up to $45 Million From K2 HealthVentures
The Daily Biotech Pulse: Equillium Issues Positive Regulatory Update, Biogen In-Licenses Multiple Sclerosis Drug, Aridis Releases COVID-19 Antibody Cocktail Data
Frequently asked questionsWhat percentage of ASLAN Pharmaceuticals is owned by institutions?
Currently 39.498% of ASLAN Pharmaceuticals shares are held by institutions. How many people work for ASLAN Pharmaceuticals?
Latest data suggests 18 work at ASLAN Pharmaceuticals. When does the fiscal year end for ASLAN Pharmaceuticals?
ASLAN Pharmaceuticals's fiscal year ends in December. Where is ASLAN Pharmaceuticals based?
ASLAN Pharmaceuticals's address is: 83 Clemenceau Avenue, Singapore, Singapore, 239920 What is ASLAN Pharmaceuticals's ISIN number?
ASLAN Pharmaceuticals's international securities identification number is: US04522R1014 What is ASLAN Pharmaceuticals's CUSIP number?
ASLAN Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 04522R101
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert